Background: The objective of this study is to examine thiol-disulfide homeostasis in patients with cerebral venous sinus thrombosis.
Methods: Fifty-three patients diagnosed with cerebral venous sinus thrombosis and 80 healthy volunteers were included in the study. The native thiol and total thiol concentrations were measured with the newly developed automated method. In addition, their amount of disulfide bonds was calculated.
Results: The total thiol and native thiol levels of the patients with cerebral venous sinus thrombosis were significantly lower than the healthy volunteers (p = 0.001, p = 0.001, respectively). In terms of dynamic disulfide bond formation, there was no statistically significant difference between the groups (p > 0.05). A significant negative correlation was determined between native thiol and total thiol levels and the number of sinuses that had thrombosis (r = -0.136, p = 0.033; r = -0.141, p = 0.015, respectively). There was no correlation between National Institutes of Health Stroke Scale score and thiol-disulfide homeostasis parameters.
Conclusions: This study is the first study to examine thiol-disulfide homeostasis in patients with cerebral venous sinus thrombosis. The thiol-disulfide balance is impaired under oxidative stress. This study revealed that this balance is disrupted in correlation with widespread thrombosis in patients with cerebral venous sinus thrombosis. Therefore, fortification of thiol deficiency with N-acetyl cysteine or alpha-lipoic acid can prevent the progress of thrombosis and can be beneficial in cerebral venous sinus thrombosis treatment.